Abstract
STUDY OBJECTIVE--The aim was to examine whether a high intake of aluminium containing antacids is a risk for Alzheimer's disease. DESIGN--The mortality from dementia (1970-87), coded from death certificates as underlying or contributory cause of death, was compared with national rates in a cohort of patients who had surgery for gastroduodenal ulcer disease between 1911 and 1978. SETTING--Patient data were obtained from patient records from major hospitals in western Norway. PARTICIPANTS--4179 patients were identified who met the study criteria, which included having had a documented stomach operation, having a reliably identifiable personal number, and being alive on Jan 1, 1970. MEASUREMENTS AND MAIN RESULTS--The standardised mortality ratio for dementia was 1.10 (95% CI 0.85-1.40, n = 64) for all patients, while for patients operated on in the period 1967-78 it was 1.25 (95% CI 0.66-2.13, n = 13). CONCLUSIONS--As the majority of patients operated on after 1963 have probably been heavy consumers of aluminium containing antacids, the study provides meager evidence that a high intake of aluminium is an important risk factor for Alzheimer's disease, the major cause of dementia. However, the possibility of a raised mortality from Alzheimer's disease cannot be ruled out due to probable misclassification both in diagnosis and exposure. In addition, the observation period may have been too short to detect an effect since the latent period for Alzheimer's disease may be very long.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amaducci L. A., Fratiglioni L., Rocca W. A., Fieschi C., Livrea P., Pedone D., Bracco L., Lippi A., Gandolfo C., Bino G. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology. 1986 Jul;36(7):922–931. doi: 10.1212/wnl.36.7.922. [DOI] [PubMed] [Google Scholar]
- Bertholf R. L. Aluminum and Alzheimer's disease: perspectives for a cytoskeletal mechanism. Crit Rev Clin Lab Sci. 1987;25(3):195–210. doi: 10.3109/10408368709105882. [DOI] [PubMed] [Google Scholar]
- Bertholf R. L., Herman M. M., Savory J., Carpenter R. M., Sturgill B. C., Katsetos C. D., Vandenberg S. R., Wills M. R. A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. Toxicol Appl Pharmacol. 1989 Mar 15;98(1):58–74. doi: 10.1016/0041-008x(89)90134-8. [DOI] [PubMed] [Google Scholar]
- Birchall J. D., Chappell J. S. Aluminum, chemical physiology, and Alzheimer's disease. Lancet. 1988 Oct 29;2(8618):1008–1010. doi: 10.1016/s0140-6736(88)90754-4. [DOI] [PubMed] [Google Scholar]
- Broe G. A., Henderson A. S., Creasey H., McCusker E., Korten A. E., Jorm A. F., Longley W., Anthony J. C. A case-control study of Alzheimer's disease in Australia. Neurology. 1990 Nov;40(11):1698–1707. doi: 10.1212/wnl.40.11.1698. [DOI] [PubMed] [Google Scholar]
- Chandra V., Bharucha N. E., Schoenberg B. S. Patterns of mortality from types of dementia in the United States, 1971 and 1973-1978. Neurology. 1986 Feb;36(2):204–208. doi: 10.1212/wnl.36.2.204. [DOI] [PubMed] [Google Scholar]
- Colin-Jones D., Langman M. J., Lawson D. H., Vessey M. P. Alzheimer's disease in antacid users. Lancet. 1989 Jun 24;1(8652):1453–1453. doi: 10.1016/s0140-6736(89)90159-1. [DOI] [PubMed] [Google Scholar]
- Farrar G., Altmann P., Welch S., Wychrij O., Ghose B., Lejeune J., Corbett J., Prasher V., Blair J. A. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Lancet. 1990 Mar 31;335(8692):747–750. doi: 10.1016/0140-6736(90)90868-6. [DOI] [PubMed] [Google Scholar]
- Flaten T. P. Mortality from dementia in Norway, 1969-83. J Epidemiol Community Health. 1989 Sep;43(3):285–289. doi: 10.1136/jech.43.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Froment D. P., Molitoris B. A., Buddington B., Miller N., Alfrey A. C. Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate. Kidney Int. 1989 Dec;36(6):978–984. doi: 10.1038/ki.1989.290. [DOI] [PubMed] [Google Scholar]
- Ganrot P. O. Metabolism and possible health effects of aluminum. Environ Health Perspect. 1986 Mar;65:363–441. doi: 10.1289/ehp.8665363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graves A. B., White E., Koepsell T. D., Reifler B. V., van Belle G., Larson E. B. The association between aluminum-containing products and Alzheimer's disease. J Clin Epidemiol. 1990;43(1):35–44. doi: 10.1016/0895-4356(90)90053-r. [DOI] [PubMed] [Google Scholar]
- Heyman A., Wilkinson W. E., Stafford J. A., Helms M. J., Sigmon A. H., Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol. 1984 Apr;15(4):335–341. doi: 10.1002/ana.410150406. [DOI] [PubMed] [Google Scholar]
- Katzman R. Alzheimer's disease. N Engl J Med. 1986 Apr 10;314(15):964–973. doi: 10.1056/NEJM198604103141506. [DOI] [PubMed] [Google Scholar]
- Kruck T. P., McLachlan D. R. Aluminum as a pathogenic factor in senile dementia of the Alzheimer type: ion specific chelation. Prog Clin Biol Res. 1989;317:1155–1167. [PubMed] [Google Scholar]
- Lione A. Aluminum toxicology and the aluminum-containing medications. Pharmacol Ther. 1985;29(2):255–285. doi: 10.1016/0163-7258(85)90032-4. [DOI] [PubMed] [Google Scholar]
- Martin R. B. The chemistry of aluminum as related to biology and medicine. Clin Chem. 1986 Oct;32(10):1797–1806. [PubMed] [Google Scholar]
- Martyn C. N., Barker D. J., Osmond C., Harris E. C., Edwardson J. A., Lacey R. F. Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet. 1989 Jan 14;1(8629):59–62. [PubMed] [Google Scholar]
- Martyn C. N., Pippard E. C. Usefulness of mortality data in determining the geography and time trends of dementia. J Epidemiol Community Health. 1988 Jun;42(2):134–137. doi: 10.1136/jech.42.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLachlan D. R., Lukiw W. J., Kruck T. P. New evidence for an active role of aluminum in Alzheimer's disease. Can J Neurol Sci. 1989 Nov;16(4 Suppl):490–497. doi: 10.1017/s0317167100029826. [DOI] [PubMed] [Google Scholar]
- Pennington J. A. Aluminium content of foods and diets. Food Addit Contam. 1988 Apr-Jun;5(2):161–232. doi: 10.1080/02652038809373696. [DOI] [PubMed] [Google Scholar]
- Recker R. R., Blotcky A. J., Leffler J. A., Rack E. P. Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med. 1977 Nov;90(5):810–815. [PubMed] [Google Scholar]
- Slanina P., Frech W., Ekström L. G., Löf L., Slorach S., Cedergren A. Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem. 1986 Mar;32(3):539–541. [PubMed] [Google Scholar]
- Tomlinson B. E., Blessed G., Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970 Sep;11(3):205–242. doi: 10.1016/0022-510x(70)90063-8. [DOI] [PubMed] [Google Scholar]
- Viste A., Bjørnestad E., Opheim P., Skarstein A., Thunold J., Hartveit F., Eide G. E., Eide T. J., Søreide O. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet. 1986 Aug 30;2(8505):502–505. doi: 10.1016/s0140-6736(86)90368-5. [DOI] [PubMed] [Google Scholar]
- Weberg R., Berstad A. Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. Eur J Clin Invest. 1986 Oct;16(5):428–432. doi: 10.1111/j.1365-2362.1986.tb01018.x. [DOI] [PubMed] [Google Scholar]